Keswani Sanjay Chandru bought NBIX

June 2, 2026 · Form 4 insider transaction

Keswani Sanjay Chandru bought 3,212 shares of Neurocrine Biosciences, Inc. at $0.00 per share, a transaction worth N/A. The trade was recorded as option exercise and disclosed on an SEC Form 4, filed 2 days after the transaction.